Clinical usefulness of lanthanum carbonate for serum phosphate control in difficult patients

about

Clinical usefulness of lanthanum carbonate for serum phosphate control in difficult patients

Item

http://www.wikidata.org/entity/Q57218915

description

scientific article published on 11 November 2010

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 2012

@uk

name

Clinical usefulness of lanthan ...... control in difficult patients

@en

Clinical usefulness of lanthan ...... control in difficult patients

@nl

type

Item

label

Clinical usefulness of lanthan ...... control in difficult patients

@en

Clinical usefulness of lanthan ...... control in difficult patients

@nl

prefLabel

Clinical usefulness of lanthan ...... control in difficult patients

@en

Clinical usefulness of lanthan ...... control in difficult patients

@nl

P1476

Clinical usefulness of lanthan ...... control in difficult patients

@en

P2093

A Ruiz

http://www.w3.org/2001/XMLSchema#string

J C Martínez-Ocaña

http://www.w3.org/2001/XMLSchema#string

L Betancourt

http://www.w3.org/2001/XMLSchema#string

M P Valenzuela

http://www.w3.org/2001/XMLSchema#string

T López

http://www.w3.org/2001/XMLSchema#string

V Esteve

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review.

Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data.

A comparison of observational studies and randomized, controlled trials.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study

Calcium and the saga of the binders: accumulating controversy, or building consensus?

Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.

Lanthanum carbonate is an effective hypophosphatemic agent for hemodialysis patients intolerant of other phosphate binders.

Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.

Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment

P304

231-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11255-010-9860-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xavier Calvet

Jaume Almirall

Xavier Calvet

P577

2010-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21069570

http://www.w3.org/2001/XMLSchema#string